Selective COX-2 inhibitors. Part 2: Synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides

Shwu Jiuan Lin; Wei Jern Tsai; Wen Fei Chiou; Tsang Hsiung Yang; Li Ming Yang

doi:10.1016/j.bmc.2007.11.033

Selective COX-2 inhibitors. Part 2: Synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides

Shwu Jiuan Lin
, Wei Jern Tsai
, Wen Fei Chiou
, Tsang Hsiung Yang
, Li Ming Yang

Research output: Contribution to journal › Article › peer-review

32 Citations (Scopus)

Abstract

Two series of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamide derivatives were designed and synthesized for the evaluation as selective cyclooxygenase-2 (COX-2) inhibitors in a cellular assay using human whole blood (HWB). Extensive structure-activity relationships (SAR) were studied within these series. Several compounds were found to be novel and selective COX-2 inhibitors. Among them, the most potent and selective was 4-(3-carboxy-4-hydroxy-benzylideneamino)benzenesulfonamide (20, LA2135), (IC₅₀'s for COX-1: 85.13 μM; COX-2: 0.74 μM; SI: 114.5), being more active COX-2 selective than celecoxib.

Original language	English
Pages (from-to)	2697-2706
Number of pages	10
Journal	Bioorganic and Medicinal Chemistry
Volume	16
Issue number	5
DOIs	https://doi.org/10.1016/j.bmc.2007.11.033
Publication status	Published - Mar 1 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Anti-inflammatory
Benzenesulfonamide
Benzylideneamino
Isosterism
Phenyliminomethyl
Resveratrol
SAR
Selective COX-2 inhibitors

ASJC Scopus subject areas

Drug Discovery
Molecular Medicine
Molecular Biology
Biochemistry
Clinical Biochemistry
Pharmaceutical Science
Organic Chemistry

Access to Document

10.1016/j.bmc.2007.11.033

Cite this

@article{83492006d3ff4f03b879f70a67dc04fb,

title = "Selective COX-2 inhibitors. Part 2: Synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides",

abstract = "Two series of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamide derivatives were designed and synthesized for the evaluation as selective cyclooxygenase-2 (COX-2) inhibitors in a cellular assay using human whole blood (HWB). Extensive structure-activity relationships (SAR) were studied within these series. Several compounds were found to be novel and selective COX-2 inhibitors. Among them, the most potent and selective was 4-(3-carboxy-4-hydroxy-benzylideneamino)benzenesulfonamide (20, LA2135), (IC50's for COX-1: 85.13 μM; COX-2: 0.74 μM; SI: 114.5), being more active COX-2 selective than celecoxib.",

keywords = "Anti-inflammatory, Benzenesulfonamide, Benzylideneamino, Isosterism, Phenyliminomethyl, Resveratrol, SAR, Selective COX-2 inhibitors",

author = "Lin, \{Shwu Jiuan\} and Tsai, \{Wei Jern\} and Chiou, \{Wen Fei\} and Yang, \{Tsang Hsiung\} and Yang, \{Li Ming\}",

year = "2008",

month = mar,

day = "1",

doi = "10.1016/j.bmc.2007.11.033",

language = "English",

volume = "16",

pages = "2697--2706",

journal = "Bioorganic and Medicinal Chemistry",

issn = "0968-0896",

publisher = "Elsevier Ltd",

number = "5",

}

TY - JOUR

T1 - Selective COX-2 inhibitors. Part 2

T2 - Synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides

AU - Lin, Shwu Jiuan

AU - Tsai, Wei Jern

AU - Chiou, Wen Fei

AU - Yang, Tsang Hsiung

AU - Yang, Li Ming

PY - 2008/3/1

Y1 - 2008/3/1

N2 - Two series of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamide derivatives were designed and synthesized for the evaluation as selective cyclooxygenase-2 (COX-2) inhibitors in a cellular assay using human whole blood (HWB). Extensive structure-activity relationships (SAR) were studied within these series. Several compounds were found to be novel and selective COX-2 inhibitors. Among them, the most potent and selective was 4-(3-carboxy-4-hydroxy-benzylideneamino)benzenesulfonamide (20, LA2135), (IC50's for COX-1: 85.13 μM; COX-2: 0.74 μM; SI: 114.5), being more active COX-2 selective than celecoxib.

AB - Two series of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamide derivatives were designed and synthesized for the evaluation as selective cyclooxygenase-2 (COX-2) inhibitors in a cellular assay using human whole blood (HWB). Extensive structure-activity relationships (SAR) were studied within these series. Several compounds were found to be novel and selective COX-2 inhibitors. Among them, the most potent and selective was 4-(3-carboxy-4-hydroxy-benzylideneamino)benzenesulfonamide (20, LA2135), (IC50's for COX-1: 85.13 μM; COX-2: 0.74 μM; SI: 114.5), being more active COX-2 selective than celecoxib.

KW - Anti-inflammatory

KW - Benzenesulfonamide

KW - Benzylideneamino

KW - Isosterism

KW - Phenyliminomethyl

KW - Resveratrol

KW - SAR

KW - Selective COX-2 inhibitors

UR - https://www.scopus.com/pages/publications/40749088834

UR - https://www.scopus.com/pages/publications/40749088834#tab=citedBy

U2 - 10.1016/j.bmc.2007.11.033

DO - 10.1016/j.bmc.2007.11.033

M3 - Article

C2 - 18063374

AN - SCOPUS:40749088834

SN - 0968-0896

VL - 16

SP - 2697

EP - 2706

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

IS - 5

ER -

Selective COX-2 inhibitors. Part 2: Synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides

Abstract

UN SDGs

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this